Cell and Gene Therapy Catapult is a place where academics, businesses and clinicians, with a special interest in cell therapies, work together to focus on the commercial development of cutting-edge technologies in cell therapy.
ISG has completed work on a multi-million-pound project to create a state-of-the-art eye hospital in London's renowned Marylebone medical district for high-end ophthalmic specialist Optegra.
Illumina Inc, headquartered in California, develops innovative array-based solutions for DNA, RNA, and protein analysis. Its technologies are used by a range of academic, government, pharmaceutical and biotechnology institutions around the globe, with offices in the US, Japan, China, Singapore, Australia and the UK.
ISG is helping to pioneer scientific discovery through delivering British Antarctic Survey’s (BAS) state-of-the-art Aurora Cambridge Innovation Centre at its headquarters in Cambridge.
We are transforming the central London high-rise One Mabledon Place into a new state-of-the-art pathology facility for Health Services Laboratories (HSL).
The Centre for Stem Cells and Regenerative Medicine received an extensive upgrade of existing mechanical, electrical and plumbing services.